Correction to: Licochalcone A induces apoptosis through endoplasmic reticulum stress via a phospholipase Cγ1-, Ca2+-, and reactive oxygen species-dependent pathway in HepG2 human hepatocellular carcinoma cells (Apoptosis, (2014), 19, 4, (682-697), 10.1007/s10495-013-0955-y);Licochalcone A induces apoptosis through endoplasmic reticulum stress via a phospholipase Cγ1-, Ca2+-, and reactive oxygen species-dependent pathway in HepG2 human hepatocellular carcinoma cells

Apoptosis

Volumn 19, Issue 4, 2014, Pages 682-697

  Choi, A Young ^a   Choi, Ji Hyun ^a   Hwang, Keun Young ^a   Jeong, Yeon Ju ^a   Choe, Wonchae ^a   Yoon, Kyung Sik ^a   Ha, Joohun ^a   Kim, Sung Soo ^a   Youn, Jang Hyun ^a,b   Yeo, Eui Ju ^c   Kang, Insug ^a  

^a Kyung Hee University Hospital   (South Korea)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c Gachon University   (South Korea)

Author keywords

Apoptosis; Calcium; ER stress; HepG2 cells; Licochalcone A; PLC 1

Indexed keywords

2 AMINOETHOXYDIPHENYLBORANE; 4 PHENYLBUTYRIC ACID; ACETYLCYSTEINE; CALCIUM; CASPASE 3; CASPASE 4; CASPASE 9; CCAAT ENHANCER BINDING PROTEIN; FLUORESCEIN ISOTHIOCYANATE; LICOCHALCONE A; LIPOCORTIN 5; PHOSPHOLIPASE C GAMMA1; REACTIVE OXYGEN METABOLITE; SALUBRINAL; SCATTER FACTOR RECEPTOR; SORAFENIB; SUNITINIB; THAPSIGARGIN; VASCULOTROPIN RECEPTOR 2; ANTINEOPLASTIC AGENT; CASPASE; CHALCONE DERIVATIVE; HEAT SHOCK PROTEIN; PHOSPHOLIPASE C GAMMA; PROTEIN TYROSINE KINASE; RON PROTEIN; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2, HUMAN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CELL CULTURE; CELL DEATH; CELL STRAIN HEPG2; CELL VIABILITY; DNA CONTENT; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM STRESS; ENZYME PHOSPHORYLATION; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MTT ASSAY; NONHUMAN; PRIORITY JOURNAL; RNA INTERFERENCE; WESTERN BLOTTING; CELL LINE; DRUG EFFECTS; HEPG2 CELL LINE; METABOLISM; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CALCIUM; CASPASES; CELL LINE; CHALCONES; ENDOPLASMIC RETICULUM STRESS; HEAT-SHOCK PROTEINS; HEP G2 CELLS; HUMANS; PHOSPHOLIPASE C GAMMA; REACTIVE OXYGEN SPECIES; RECEPTOR PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84896398309     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-018-1493-4     Document Type: Erratum

References (50)

1. Gorlach A, Klappa P, Kietzmann T (2006) The endoplasmic reticulum: folding, calcium homeostasis, signaling, and redox control. Antioxid Redox Signal 8:1391-1418
2. Boyce M, Yuan J (2006) Cellular response to endoplasmic reticulum stress: a matter of life or death. Cell Death Differ 13:363-373
3. Logue SE, Cleary P, Saveljeva S, Samali A (2013) New directions in ER stress-induced cell death. Apoptosis 18:537-546
4. Kim I, Xu W, Reed JC (2008) Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities. Nat Rev Drug Discov 7:1013-1030
5. 2+ homeostasis after ER stress. J Cell Sci 121:3636-3648
6. Santos CX, Tanaka LY, Wosniak J, Laurindo FR (2009) Mechanisms and implications of reactive oxygen species generation during the unfolded protein response: roles of endoplasmic reticulum oxidoreductases, mitochondrial electron transport, and NADPH oxidase. Antioxid Redox Signal 11:2409-2427
7. Yan Y, Wei CL, Zhang WR, Cheng HP, Liu J (2006) Cross-talk between calcium and reactive oxygen species signaling. Acta Pharmacol Sin 27:821-826
8. Mandic A, Hansson J, Linder S, Shoshan MC (2003) Cisplatin induces endoplasmic reticulum stress and nucleus-independent apoptotic signaling. J Biol Chem 278:9100-9106
9. Schonthal AH (2013) Pharmacological targeting of endoplasmic reticulum stress signaling in cancer. Biochem Pharmacol 85:653-666
10. Hoshida Y, Toffanin S, Lachenmayer A, Villanueva A, Minguez B, Llovet JM (2010) Molecular classification and novel targets in hepatocellular carcinoma: recent advancements. Semin Liver Dis 30:35-51
11. Huynh H (2010) Molecularly targeted therapy in hepatocellular carcinoma. Biochem Pharmacol 80:550-560
12. Spangenberg HC, Thimme R, Blum HE (2009) Targeted therapy for hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol 6:423-432
13. Furusawa J, Funakoshi-Tago M, Tago K et al (2009) Licochalcone A significantly suppresses LPS signaling pathway through the inhibition of NF-kappaB p65 phosphorylation at serine 276. Cell Signal 21:778-785
14. Mi-Ichi F, Miyadera H, Kobayashi T et al (2005) Parasite mitochondria as a target of chemotherapy: inhibitory effect of licochalcone A on the Plasmodium falciparum respiratory chain. Ann N Y Acad Sci 1056:46-54
15. Fu Y, Hsieh TC, Guo J et al (2004) Licochalcone-A, a novel flavonoid isolated from licorice root (Glycyrrhiza glabra), causes G2 and late-G1 arrests in androgen-independent PC-3 prostate cancer cells. Biochem Biophys Res Commun 322:263-270
16. Lee CK, Son SH, Park KK et al (2008) Licochalcone A inhibits the growth of colon carcinoma and attenuates cisplatin-induced toxicity without a loss of chemotherapeutic efficacy in mice. Basic Clin Pharmacol Toxicol 103:48-54
17. Kim YH, Shin EK, Kim DH, Lee HH, Park JH, Kim JK (2010) Antiangiogenic effect of licochalcone A. Biochem Pharmacol 80:1152-1159
18. Lee CS, Kwak SW, Kim YJ et al (2012) Guanylate cyclase activator YC-1 potentiates apoptotic effect of licochalcone A on human epithelial ovarian carcinoma cells via activation of death receptor and mitochondrial pathways. Eur J Pharmacol 683:54-62
19. Xiao XY, Hao M, Yang XY et al (2011) Licochalcone A inhibits growth of gastric cancer cells by arresting cell cycle progression and inducing apoptosis. Cancer Lett 302:69-75
20. Yo YT, Shieh GS, Hsu KF, Wu CL, Shiau AL (2009) Licorice and licochalcone-A induce autophagy in LNCaP prostate cancer cells by suppression of Bcl-2 expression and the mTOR pathway. J Agric Food Chem 57:8266-8273
21. Kim JK, Shin EK, Park JH, Kim YH (2010) Antitumor and antimetastatic effects of licochalcone A in mouse models. J Mol Med (Berl) 88:829-838
22. Yeh TC, Chiang PC, Li TK et al (2007) Genistein induces apoptosis in human hepatocellular carcinomas via interaction of endoplasmic reticulum stress and mitochondrial insult. Biochem Pharmacol 73:782-792
23. Hseu YC, Lee MS, Wu CR et al (2012) The chalcone flavokawain B induces G2/M cell-cycle arrest and apoptosis in human oral carcinoma HSC-3 cells through the intracellular ROS generation and downregulation of the Akt/p38 MAPK signaling pathway. J Agric Food Chem 60:2385-2397
24. Choi JH, Lee JY, Choi AY et al (2012) Apicidin induces endoplasmic reticulum stress- and mitochondrial dysfunction-associated apoptosis via phospholipase Cgamma1- and Ca(2 +)-dependent pathway in mouse Neuro-2a neuroblastoma cells. Apoptosis 17:1340-1358
25. 2+]i via inositol 1,4,5-triphosphate production and activates protein kinase C gamma and -delta via phosphatidylserine binding site: implication in apoptosis in U937 cells. Mol Pharmacol 72:1545-1556
26. Breckenridge DG, Germain M, Mathai JP, Nguyen M, Shore GC (2003) Regulation of apoptosis by endoplasmic reticulum pathways. Oncogene 22:8608-8618
27. Pfaffenbach KT, Gentile CL, Nivala AM, Wang D, Wei Y, Pagliassotti MJ (2010) Linking endoplasmic reticulum stress to cell death in hepatocytes: roles of C/EBP homologous protein and chemical chaperones in palmitate-mediated cell death. Am J Physiol Endocrinol Metab 298:1027-1035
28. Orrenius S, Zhivotovsky B, Nicotera P (2003) Regulation of cell death: the calcium-apoptosis link. Nat Rev Mol Cell Biol 4:552-565
29. Patterson RL, van Rossum DB, Nikolaidis N, Gill DL, Snyder SH (2005) Phospholipase C-gamma: diverse roles in receptor-mediated calcium signaling. Trends Biochem Sci 30:688-697
30. Meyer RD, Latz C, Rahimi N (2003) Recruitment and activation of phospholipase Cgamma1 by vascular endothelial growth factor receptor-2 are required for tubulogenesis and differentiation of endothelial cells. J Biol Chem 278:16347-16355
31. Cervello M, Bachvarov D, Lampiasi N et al (2012) Molecular mechanisms of sorafenib action in liver cancer cells. Cell Cycle 11:2843-2855
32. Liu L, Cao Y, Chen C et al (2006) Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5. Cancer Res 66:11851-11858
33. Gan HK, Seruga B, Knox JJ (2009) Sunitinib in solid tumors. Expert Opin Investig Drugs 18:821-834
34. Aden DP, Fogel A, Plotkin S, Damjanov I, Knowles BB (1979) Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line. Nature 282:615-616
35. Knowles BB, Howe CC, Aden DP (1980) Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen. Science 209:497-499
36. Kim SO, Park JG, Lee YI (1996) Increased expression of the insulin-like growth factor I (IGF-I) receptor gene in hepatocellular carcinoma cell lines: implications of IGF-I receptor gene activation by hepatitis B virus X gene product. Cancer Res 56:3831-3836
37. Pelicano H, Carney D, Huang P (2004) ROS stress in cancer cells and therapeutic implications. Drug Resist Updat 7:97-110
38. Berridge MJ, Lipp P, Bootman MD (2000) The versatility and universality of calcium signalling. Nat Rev Mol Cell Biol 1:11-21
39. 2+ stores by specific inhibition of the endoplasmic reticulum Ca2(+)-ATPase. Proc Natl Acad Sci USA 87:2466-2470
40. 2+-dependent apoptosis. Blood 111:2354-2363
41. Gao J, Inagaki Y, Song P, Qu X, Kokudo N, Tang W (2012) Targeting c-Met as a promising strategy for the treatment of hepatocellular carcinoma. Pharmacol Res 65:23-30
42. Lu KV, Chang JP, Parachoniak CA et al (2012) VEGF inhibits tumor cell invasion and mesenchymal transition through a MET/VEGFR2 complex. Cancer Cell 22:21-35
43. Fischer OM, Giordano S, Comoglio PM, Ullrich A (2004) Reactive oxygen species mediate Met receptor transactivation by G protein-coupled receptors and the epidermal growth factor receptor in human carcinoma cells. J Biol Chem 279:28970-28978
44. Zhang S, Zhau HE, Osunkoya AO et al (2010) Vascular endothelial growth factor regulates myeloid cell leukemia-1 expression through neuropilin-1- dependent activation of c-MET signaling in human prostate cancer cells. Mol Cancer 9:9
45. Sangwan V, Paliouras GN, Abella JV et al (2008) Regulation of the Met receptor-tyrosine kinase by the protein-tyrosine phosphatase 1B and T-cell phosphatase. J Biol Chem 283:34374-34383
46. Holmes K, Roberts OL, Thomas AM, Cross MJ (2007) Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition. Cell Signal 19:2003-2012
47. Narasimhan P, Liu J, Song YS, Massengale JL, Chan PH (2009) VEGF Stimulates the ERK 1/2 signaling pathway and apoptosis in cerebral endothelial cells after ischemic conditions. Stroke 40:1467-1473
48. Tulasne D, Foveau B (2008) The shadow of death on the MET tyrosine kinase receptor. Cell Death Differ 15:427-434
49. Yuan X, Yu B, Wang Y et al (2013) Involvement of endoplasmic reticulum stress in isoliquiritigenin-induced SKOV-3 cell apoptosis. Recent Pat Anticancer Drug Discov 8:191-199
50. Wang Z, Wang N, Han S et al (2013) Dietary compound isoliquiritigenin inhibits breast cancer neoangiogenesis via VEGF/VEGFR-2 signaling pathway. PLoS One 8:e68566